Dr Nihad Alhashimi


I am a PhD, MSc pharmaceutical scientist specialising in R&D, analytical techniques and drug delivery systems with extensive research and academic skills. Both industry and teaching made me highly aware of pre-formulation production and development, aspects of pharmacy, microbiology, and analytical techniques.

I completed my BPharm in Iraq- College of Pharmacy in 2008. I have worked as a pharmacist in Iraq in community and hospital settings. I joined Kingston University to develop my research skills, obtaining MSc in Pharmaceutical sciences followed by a PhD in pharmaceutical sciences, specifically oral drug delivery.  

During my research, I participated in different scientific events nationally and internationally, and the quality of my research has been acknowledged internationally with the first prize for the best poster award for the pharmaceutically relevant poster from Glaxo Smith Kline at the 9th Granulation Workshop held in Switzerland in 2019. I was also awarded the Achievement Awards for PGR students at Kingston university in 2020.

Academic responsibilities



  • Bachelor of Pharmacy (BPharm), Al-Mustansyria University, Iraq.
  • Masters of Pharmaceutical science, Kingston University London, UK.
  • Doctor of Philosophy (Oral drug delivery), Kingston University London, UK.

Teaching and learning

Working as a university lecturer for undergraduate and postgraduate modules enhanced my teaching experience in Higher Education and research long-term experience and skills. These include effective time management, working under pressure, organisation, communication, supervision, professionalism, and leadership. I contribute to the teaching and assessment, in the School of Life Sciences, Pharmacy and Chemistry. 

Modules covered:

  • Drug Design and Medicine Development
  • Analytical Chemistry
  • Sterile Product – Making medicines
  • Microbiology and biosciences 

As an academic member with an ethnic minority background, my teaching experience with MPharm and master students in chemistry and pharmaceutical sciences improved by providing excellent support for ethnic minorities and working in an inclusive and diverse environment. I attained a lively atmosphere by making one-to-one online sessions, preparing interactive workshops, and advantaging the students from online resources. Supervising masters and undergrad students enabled me to experience designing projects, managing, and organising teamwork. I worked effectively as part of a collaborative research group to arrange a collaboration with other universities. This also has enabled me to be a peer-reviewer in Pharmaceutical Formulation and Drug Delivery journal to assess the validity, quality, and originality of articles.

I attained excellent skills by participating in a Black and Ethnic Minority (BME) mentoring scheme that enabled me to provide additional targeted support for students. This also enriched my experience to provide support to postgraduate students during the pandemic. 

Qualifications and expertise

  • Associate Fellow of Higher Education Academy (AFHEA), 2018

Undergraduate courses taught

Postgraduate courses taught


My research and lab experience focused on preparing new oral formulations from pharmaceutical polymers to prepare modified-release formulations (tablets, pellets, microparticles). I used various physicochemical characterisation techniques such as HPLC, GC, Karl Fischer, titration, UV-vis, FT-IR, HNMR, DSC, XRPD, hot plate microscopy, SEM, solubility, freeze & spray drying, extrusion spheronisation, pellets coating and dissolution studies according to GMP. I have a complete understanding of British and European pharmacopoeia. To ensure high accuracy and quality for my research findings, I developed and validated new HPLC methods for different APIs.  

My research focuses on oral dosage forms with modified release properties. The presence of different routes of drug administration and despite the advantages offered by each one, the oral route is still the most preferred delivery system. However, Dysphagia and swallowing problems that could be associated with many diseases such as mouth ulcers, and oesophageal and mouth cancer make it difficult for the patient to swallow oral solid dosage forms. Orodispersible tablets (ODTs) were introduced to overcome swallowing difficulties. These tablets disintegrate in the mouth allowing the fast drug release into the biological system. Orodispersible tablets are also known as fast-dissolving tablets. Many approaches have been explored and developed in order to improve ODTs properties. Sustained-release ODTs that are based on micro/nanoparticles have arisen from these studies, to decrease dose frequency and enhance patient compliance.

Oral/Poster presentations 

  • The correlation between particle size and elastic properties of pharmaceutical polymers. Nihad AL-hashimi, Abyan Hodon, Raid Alany, Mohammed Khoder, Amr Elshaer. Poster presentation at UKICRS conference, University of Strathclyde, 2017
  • Orodispersible tablets of modified propranolol hydrochloride release across the particulate system. Nihad Al-Hashimi, Rona Faizy, Raid Alany, Mohammed Khoder, Amr Elshaer. Oral presentations at Chemistry & Pharmacy Research Group, Kingston University London, 2019
  • Modification of indomethacin release across Orodispersible tablets using pH-dependent polymers. Nihad Al-hashimi1, Raid Alany1, Mohammed Khoder1, Amr Elshaer1. Poster presentation at Sheffield university workshop, Switzerland, 2019
  • Orodispersible tablets of modified indomethacin release across the particulate system. Nihad Al-hashimi, Raid Alany, Mohammed Khoder, Amr Elshaer. Poster presentation at the APS International PharmSci Conference, University of Greenwich, 2019
  • Modification of indomethacin release using Orodispersible tablets through Eudragit L100 pellets. Nihad Al-hashimi1, Raid Alany1, Mohammed Khoder1, Amr Elshaer1. Poster presentation at Royal Society of Chemistry event, Kingston University London, 2019


  • Al-Hashimi, N., Babenko, M., Saaed, M., Kargar, N. and ElShaer, A., 2021. The Impact of Natural and Synthetic Polymers in Formulating Micro and Nanoparticles for Anti-Diabetic Drugs. Current Drug Delivery, [online] 18(3), pp.271-288
  • Al-Hashimi, N., Begg, N., Alany, R., Hassanin, H. and Elshaer, A., 2018. Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles. Pharmaceutics, [online] 10(4), p.176.


Jump to: Article | Thesis
Number of items: 3.


Al-Hashimi, Nihad, Babenko, Mai, Saaed, Maria, Kargar, Negeen and ElShaer, Amr (2021) The impact of natural and synthetic polymers in formulating micro and nanoparticles for antidiabetic drugs. Current Drug Delivery, 18(3), pp. 271-288. ISSN (print) 1567-2018

Al-Hashimi, Nihad, Begg, Nazish, Alany, Raid G., Hassanin, Hany and Elshaer, Amr (2018) Oral modified release multiple-unit particulate systems : compressed pellets, microparticles and nanoparticles. Pharmaceutics, 10(4), p. 176. ISSN (print) 1999-4923


Al-Hashimi, Nihad (2021) Engineering of multiparticulate systems to modify the drug release across orally disintegrating tablets. (PhD thesis), Kingston University, .

This list was generated on Sat Apr 20 07:19:21 2024 BST.

Business, knowledge transfer and international

My research is related to the pharmaceutical industry developing oral pharmaceutical formulations, I build collaborations with academic staff and companies.

Social media